Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF)

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 6, 2007, Pages 1216-1222

  Bohnert, Jürgen A ^a   Schuster, Sabine ^a   Fähnrich, Eva ^a   Trittler, Rainer ^a   Kern, Winfried V ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

E. coli; Fluoroquinolones; Nosocomial pathogens

Indexed keywords

AZITHROMYCIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINAFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; ETHIDIUM BROMIDE; GATIFLOXACIN; GEMIFLOXACIN; KETOLIDE; LEVOFLOXACIN; LINEZOLID; MACROLIDE; NOVOBIOCIN; OXACILLIN; PHENYLALANINE; PYRONINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; TELITHROMYCIN; TETRACYCLINE; VALINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM MUTANT; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG EXPOSURE; ESCHERICHIA COLI; GENE EXPRESSION; GENE INACTIVATION; GENE OVEREXPRESSION; GENE SEQUENCE; HOMOLOGOUS RECOMBINATION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; POINT MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE;

ACETAMIDES; ALLELES; ANTI-BACTERIAL AGENTS; DNA, BACTERIAL; DNA, COMPLEMENTARY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; OFLOXACIN; OXAZOLIDINONES; P-GLYCOPROTEINS; PHENOTYPE; PHENYLALANINE; POINT MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, BACTERIAL;

EID: 34447534306     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl426     Document Type: Article

References (41)

1. Li XZ, Nikaido, H. Efflux-mediated drug resistance in bacteria. Drugs 2004; 64: 159-204.
2. Piddock LJ. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 2006; 19: 382-402.
3. Poole K. Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 2005; 56: 20-51.
4. Kern WV, Oethinger M, Jellen-Ritter AS et al. Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother 2000; 44: 814-20.
5. Mazzariol A, Tokue Y, Kanegawa TM et al. High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrob Agents Chemother 2000; 44: 3441-3.
6. Wang H, Dzink-Fox JL, Chen M et al. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: Role of acrR mutations. Antimicrob Agents Chemother 2001; 45: 1515-21.
7. Jellen-Ritter AS, Kern WV. Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants selected with a fluoroquinolone. Antimicrob Agents Chemother 2001; 45: 1467-72.
8. Webber MA, Talukder A, Piddock LJ. Contribution of mutation at amino acid 45 of AcrR to acrB expression and ciprofloxacin resistance in clinical and veterinary Escherichia coli isolates. Antimicrob Agents Chemother 2005; 49: 4390-2.
9. Lau SY, Zgurskaya HI. Cell division defects in Escherichia coli deficient in the multidrug efflux transporter AcrEF-ToIC. J Bacteriol 2005; 187:7815-25.
10. Baranova N, Nikaido, H. The baeSR two-component regulatory system activates transcription of the yegMNOB (mdtABCD) transporter gene cluster in Escherichia coli and increases its resistance to novobiocin and deoxycholate. J Bacteriol 2002; 184: 4168-76.
11. Hirakawa H, Nishino K, Yamada J et al. Beta-lactam resistance modulated by the overexpression of response regulators of two-component signal transduction systems in Escherichia coli. J Antimicrob Chemother 2003; 52: 576-82.
12. Nagakubo S, Nishino K, Hirata T et al. The putative response regulator BaeR stimulates multidrug resistance of Escherichia coli via a novel multidrug exporter system, MdtABC. J Bacteriol 2002; 184: 4161-7.
13. Nishino K, Yamaguchi A. EvgA of the two-component signal transduction system modulates production of the YhiUV multidrug transporter in Escherichia coli. J Bacteriol 2002; 184: 2319-23.
14. Elkins CA, Mullis LB. Mammalian steroid hormones are substrates for the major RND- and MFS-type tripartite multidrug efflux pumps of Escherichia coli. J Bacteriol 2006; 188: 1191-5.
15. Masuda N, Church GM. Escherichia coli gene expression responsive to levels of the response regulator EvgA. J Bacteriol 2002; 184 6225-34.
16. Nishino K, Inazumi Y, Yamaguchi A. Global analysis of genes regulated by EvgA of the two-component regulatory system in Escherichia coli. J Bacteriol 2003; 185: 2667-72.
17. Bleuel C, Grosse C, Taudte N et al. ToIC is involved in enterobactin efflux across the outer membrane of Escherichia coli. J Bacteriol 2005; 187: 6701-7.
18. Kern WV, Steinke P, Schumacher A et al. Effect of 1 -(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. J Antimicrob Chemother 2006; 57: 339-43.
19. Ehrlich M, Trittler R, Daschner FD et al. A new and rapid method for monitoring the new oxazolidinone antibiotic linezolid in serum and urine by high performance liquid chromatography-integrated sample preparation. J Chromatogr B Biomed Sci Appl 2001; 755: 373-7.
20. Oethinger M, Kern WV, Jellen-Ritter AS et al. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother 2000; 44: 10-3.
21. Muyrers JP, Zhang Y, Testa G et al. Rapid modification of bacterial artificial chromosomes by ET-recombination. Nucleic Acids Res 1999; 27: 1555-7.
22. Zhang Y, Buchholz F, Muyrers JP et al. A new logic for DNA engineering using recombination in Escherichia coli. Nature Genet 1998; 20: 123-8.
23. Eichenbaum Z, Federle MJ, Marra D et al. Use of the lactococcal nisA promoter to regulate gene expression in Gram-positive bacteria: comparison of induction level and promoter strength. Appl Environ Microbiol 1998; 64: 2763-9.
24. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002; 30 e36.
25. Schwede T, Kopp J, Guex N et al. SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res 2003; 31: 3381-5.
26. Murakami S, Nakashima R, Yamashita E et al. Crystal structure of the bacterial multidrug efflux transporter AcrB. Nature 2002; 419: 587-93.
27. Amabile-Cuevas CF, Demple B. Molecular characterization of the soxRS genes of Escherichia coli: Two genes control a superoxide stress regulon. Nucleic Acids Res 1991; 19: 4479-84.
28. Bohnert JA, Kern WV. Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps. Antimicrob Agents Chemother 2005; 49: 849-52.
29. Nishino K, Yamaguchi A. Analysis of a complete library of putative drug transporter genes in Escherichia coli. J Bacteriol 2001; 183 5803-12.
30. Frelet A, Klein M. Insight in eukaryotic ABC transporter function by mutation analysis. FEBS Lett 2006; 580: 1064-84.
31. Paulsen IT, Brown MH, Skurray RA. Characterization of the earliest known Staphylococcus aureus plasmid encoding a multidrug efflux system. J Bacteriol 1998; 180: 3477-9.
32. Klyachko KA, Schuldiner S, Neyfakh AA. Mutations affecting substrate specificity of the Bacillus subtilis multidrug transporter Bmr. J Bacteriol 1997; 179: 2189-93.
33. Adler J, Bibi E. Determinants of substrate recognition by the Escherichia coli multidrug transporter MdfA identified on both sides of the membrane. J Biol Chem 2004; 279: 8957-65.
34. Mazurkiewicz P, Driessen AJ, Konings WN. Energetics of wildtype and mutant multidrug resistance secondary transporter LmrP of Lactococcus lactis. Biochim Biophys Acta 2004; 1658: 252-61.
35. Yu EW, McDermott G, Zgurskaya HI et al. Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump. Science 2003; 300: 976-80.
36. Yu EW, Aires JR, McDermott G et al. A periplasmic drug-binding site of the AcrB multidrug efflux pump: A crystallographic and site-directed mutagenesis study. J Bacteriol 2005; 187: 6804-15.
37. Fujihira E, Tamura N, Yamaguchi A. Membrane topology of a multidrug efflux transporter, AcrB, in Escherichia coli. J Biochem (Tokyo) 2002; 131: 145-51.
38. Hearn EM, Gray MR, Foght JM. Mutations in the central cavity and periplasmic domain affect efflux activity 'of the resistance-nodulation-division pump EmhB from Pseudomonas fluorescens cLP6a. J Bacteriol 2006; 188: 115-23.
39. Mao W, Warren MS, Black DS et al. On the mechanism of substrate specificity by resistance nodulation division (RND)-type multidrug resistance pumps: The large periplasmic loops of MexD from Pseudomonas aeruginosa are involved in substrate recognition. Mol Microbiol 2002; 46: 889-901.
40. Middlemiss JK, Poole K. Differential impact of MexB mutations on substrate selectivity of the MexAB-OprM multidrug efflux pump of Pseudomonas aeruginosa. J Bacteriol 2004; 186: 1258-69.
41. Murakami S, Tamura N, Saito A et al. Extramembrane central pore of multidrug exporter AcrB in Escherichia coli plays an important role in drug transport. J Biol Chem 2004; 279: 3743-8.